Home > Annual Financials > TTK HEALTHCARE

TTK HEALTHCARE Financial Statement Analysis
[BOM: 507747|NSE : TTKHLTCARE]

The Revenues of TTK HEALTHCARE have increased by 3.82% YoY .
The Earnings Per Share (EPS) of TTK HEALTHCARE has increased by 40.68 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

TTK HEALTHCARE Last 5 Annual Financial Results
[BOM: 507747|NSE : TTKHLTCARE]

StandaloneMar2024
Mar2023
Mar2022
Mar2021
Mar2020
Revenues ₹753 Cr₹725 Cr₹599 Cr₹476 Cr₹646 Cr
Expenses ₹715 Cr₹694 Cr₹577 Cr₹457 Cr₹617 Cr
Operating Profit (Excl OI) ₹37 Cr₹31 Cr₹22 Cr₹19 Cr₹28 Cr
Other Income ₹63 Cr₹48 Cr₹16 Cr₹9.94 Cr₹8.78 Cr
Interest ₹2.76 Cr₹5.24 Cr₹3.24 Cr₹1.71 Cr₹3.27 Cr
Depreciation ₹13 Cr₹13 Cr₹13 Cr₹13 Cr₹14 Cr
Profit Before Tax ₹84 Cr₹62 Cr₹25 Cr₹23 Cr₹19 Cr
Profit After Tax ₹63 Cr₹45 Cr₹19 Cr₹37 Cr₹12 Cr
Earnings Per Share (Rs)₹44.47₹31.61₹13.10₹26.03₹8.72
PAT Margin (%)7.945.943.097.731.91
ROE(%)6.467.016.0213.765.01
ROCE(%)8.7210.138.598.388.28
Total Debt/Equity(x)0.020.030.060.060.12

Key Financials

Market Cap : ₹ 1,777.2 Cr
Revenue (TTM) : ₹ 792.2 Cr
Net Profit(TTM) : ₹ 83.8 Cr
EPS (TTM) : ₹ 59.4
P/E (TTM) : 21.2

Industry Peers & Returns1W1M1Y
TTK HEALTHCARE -5.6% -10.3% -9.9%
SUN PHARMACEUTICAL INDUSTRIES -5.1% -9.4% 29.2%
CIPLA -1.4% -6.7% -1.5%
DR REDDYS LABORATORIES -9% -14.4% 1.4%
ZYDUS LIFESCIENCES -7% -5% 22.6%
DIVIS LABORATORIES -7.3% -10.9% 53%
MANKIND PHARMA -2.2% -13.9% 19.3%
TORRENT PHARMACEUTICALS 4.7% -1.7% 32.9%
LUPIN -5.4% -12.4% 43.4%


TTK HEALTHCARE Revenues
[BOM: 507747|NSE : TTKHLTCARE]

Y-o-Y

3.82 %

5 Yr CAGR

3.91 %

Years Revenues % Change
Mar2024 ₹753 Cr
3.82
Mar2023 ₹725 Cr
21.00
Mar2022 ₹599 Cr
25.88
Mar2021 ₹476 Cr
-26.28
Mar2020 ₹646 Cr -


TTK HEALTHCARE Operating Profit
[BOM: 507747|NSE : TTKHLTCARE]

Y-o-Y

19.07 %

5 Yr CAGR

7.17 %

Years Operating Profit % Change
Mar2024 ₹37 Cr
19.07
Mar2023 ₹31 Cr
43.56
Mar2022 ₹22 Cr
13.03
Mar2021 ₹19 Cr
-31.72
Mar2020 ₹28 Cr -

Operating Margins
Y-o-Y

14.81 %

5 Yr CAGR

3.16 %

Years Operating Margin% % Change
Mar2024 4.96%
14.81
Mar2023 4.32%
18.68
Mar2022 3.64%
-10.34
Mar2021 4.06%
-7.31
Mar2020 4.38% -

TTK HEALTHCARE Profit After Tax
[BOM: 507747|NSE : TTKHLTCARE]

Y-o-Y

40.69 %

5 Yr CAGR

50.29 %

Years Profit After Tax % Change
Mar2024 ₹63 Cr
40.69
Mar2023 ₹45 Cr
141.32
Mar2022 ₹19 Cr
-49.68
Mar2021 ₹37 Cr
198.58
Mar2020 ₹12 Cr -

PAT Margins
Y-o-Y

33.67 %

5 Yr CAGR

42.79 %

Years PAT Margin(%) % Change
Mar2024 7.94 %
33.67
Mar2023 5.94 %
92.23
Mar2022 3.09 %
-60.03
Mar2021 7.73 %
304.71
Mar2020 1.91 % -

TTK HEALTHCARE Earnings Per Share (EPS)
[BOM: 507747|NSE : TTKHLTCARE]

Y-o-Y

40.68 %

5 Yr CAGR

50.28 %

Years EPS % Change
Mar2024 ₹44
40.68
Mar2023 ₹32
141.30
Mar2022 ₹13
-49.67
Mar2021 ₹26
198.51
Mar2020 ₹8.72 -

TTK HEALTHCARE Return on Capital Employed (ROCE)
[BOM: 507747|NSE : TTKHLTCARE]

Y-o-Y

-13.92 %

5 Yr CAGR

1.30 %

Years ROCE % Change
Mar2024 8.72%
-13.92
Mar2023 10.13%
17.93
Mar2022 8.59%
2.51
Mar2021 8.38%
1.21
Mar2020 8.28% -

TTK HEALTHCARE Share Price vs Sensex

Current Share Price : ₹1,260.5
Current MarketCap: ₹ 1,777.2 Cr
Updated EOD on :Jan 28,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
TTK HEALTHCARE

-5.6%

-10.3%

-9.9%

SENSEX

0.1%

-3.6%

7.9%

TTK HEALTHCARE related INDICES

BSE Indices1W1M1Y
S&P BSE ALLCAP -0.3% -3.5% 35.8%
S&P BSE MIDSMALLCAP -7.1% -11.2% 8.4%
S&P BSE INDUSTRIALS -7.7% -13.5% 10%
S&P BSE SMALL CAP -8.2% -13.7% 9.5%
No NSE index found

You may also like the below Video Courses


FAQ about TTK HEALTHCARE Financials


How the annual revenues of TTK HEALTHCARE have changed ?

The Revenues of TTK HEALTHCARE have increased by 3.82% YoY .

How the Earnings per Share (EPS) of TTK HEALTHCARE have changed?

The Earnings Per Share (EPS) of TTK HEALTHCARE has increased by 40.68 % YoY .